These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 9537858

  • 1. Persistence of gp210 and multiple nuclear dots antibodies does not correlate with recurrence of primary biliary cirrhosis 6 years after liver transplantation.
    Dubel L, Farges O, Courvalin JC, Sebagh M, Johanet C.
    J Hepatol; 1998 Jan; 28(1):169-70. PubMed ID: 9537858
    [No Abstract] [Full Text] [Related]

  • 2. The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis.
    Luettig B, Boeker KH, Schoessler W, Will H, Loges S, Schmidt E, Worman HJ, Gershwin ME, Manns MP.
    J Hepatol; 1998 May; 28(5):824-8. PubMed ID: 9625318
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Anti-Sp100 and anti-Gp210 in the diagnosis of primary biliary cirrhosis in patients with autoimmune cholangitis].
    Romero Gómez M, Wichmann I, Otero Fernández MA, Suárez García E, Grande L, Núñez J, Nevado Santos M, Castro Fernández M.
    Gastroenterol Hepatol; 1999 Jan; 22(1):11-3. PubMed ID: 10089705
    [Abstract] [Full Text] [Related]

  • 5. Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis.
    Itoh S, Ichida T, Yoshida T, Hayakawa A, Uchida M, Tashiro-Itoh T, Matsuda Y, Ishihara K, Asakura H.
    J Gastroenterol Hepatol; 1998 Mar; 13(3):257-65. PubMed ID: 9570238
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis.
    Nakamura M, Shimizu-Yoshida Y, Takii Y, Komori A, Yokoyama T, Ueki T, Daikoku M, Yano K, Matsumoto T, Migita K, Yatsuhashi H, Ito M, Masaki N, Adachi H, Watanabe Y, Nakamura Y, Saoshiro T, Sodeyama T, Koga M, Shimoda S, Ishibashi H.
    J Hepatol; 2005 Mar; 42(3):386-92. PubMed ID: 15710222
    [Abstract] [Full Text] [Related]

  • 9. Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis.
    Nickowitz RE, Wozniak RW, Schaffner F, Worman HJ.
    Gastroenterology; 1994 Jan; 106(1):193-9. PubMed ID: 8276182
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis.
    Bogdanos DP, Liaskos C, Pares A, Norman G, Rigopoulou EI, Caballeria L, Dalekos GN, Rodes J, Vergani D.
    Hepatology; 2007 Jun; 45(6):1583; author reply 1583-4. PubMed ID: 17538935
    [No Abstract] [Full Text] [Related]

  • 12. Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein Gp210.
    Nickowitz RE, Worman HJ.
    J Exp Med; 1993 Dec 01; 178(6):2237-42. PubMed ID: 7504063
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Anti-gp210 antibodies in sera of patients with primary biliary cirrhosis. Identification of a 64 kD fragment of gp210 as a major epitope.
    Wesierska-Gadek J, Hohenauer H, Hitchman E, Penner E.
    Hum Antibodies Hybridomas; 1996 Dec 01; 7(4):167-74. PubMed ID: 9140728
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Antinuclear antibodies in primary biliary cirrhosis].
    Mzali S, Johanet C, Chrétien P, Abuaf N.
    Gastroenterol Clin Biol; 1989 Dec 01; 13(8-9):690-5. PubMed ID: 2680726
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.